Clinical Trial Update: A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of Lu AG13909 for congenital adrenal hyperplasia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Lu AG13909

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Congenital Adrenal Hyperplasia | Phase 1, Phase 2 | Status: RECRUITING